Thanks for the reply Quiltman
You wrote,
But it could be that the move from OTC to prescription has eased the requirements from the Lead Reviewer somewhat.
So CDX are trying to gain clearance for prescription only ? Was this officially stated or communicated?
I think the prescription channel is a lot more lucrative and makes more sense initially with production.
- Forums
- ASX - By Stock
- 2020
CDX
cardiex limited
Add to My Watchlist
2.44%
!
4.0¢

Thanks for the reply Quiltman You wrote, But it could be that...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
4.0¢ |
Change
-0.001(2.44%) |
Mkt cap ! $17.94M |
Open | High | Low | Value | Volume |
4.0¢ | 4.1¢ | 4.0¢ | $15.12K | 377.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 155651 | 4.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.2¢ | 22200 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 155651 | 0.040 |
1 | 15000 | 0.039 |
3 | 314000 | 0.038 |
4 | 657100 | 0.037 |
2 | 263210 | 0.036 |
Price($) | Vol. | No. |
---|---|---|
0.042 | 22200 | 1 |
0.045 | 157414 | 2 |
0.050 | 100000 | 1 |
0.052 | 180000 | 1 |
0.080 | 100799 | 1 |
Last trade - 15.18pm 20/06/2025 (20 minute delay) ? |
Featured News
CDX (ASX) Chart |